Foghorn Therapeutics Inc.

7.82 USD
-0.12 (-1.51%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Foghorn Therapeutics Inc. stock is up 164.19% since 30 days ago. The next earnings date is Mar 15, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 75% of the previous 3 March’s closed higher than February. In the last 1 Unusual Options Trades, there were 1 CALL.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
13 Feb 17:12 21 Jun, 2024 5.00 CALL 150 80

About Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc. is developing a small molecule inhibitor of the enzymatic activity of BRG1 and BRM for the treatment of metastatic uveal melanoma and relapsed and/or refractory acute myeloid leukemia and myelodysplastic syndrome. The company is also developing an enzyme inhibitor and protein degrader as selective modulators of BRM.